Formulation D for pneumococcal infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Jan 2025: Trial registered, NCT06790290
  2. 27 Jan 2025: Trial started, NCT06790290

The trials

NCT06790290: Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

State
Under way
Phase
Phase 2
People
421 taking part
Started
27 Jan 2025
Primary completion
3 Apr 2025
Arms
Group C (Hybrid dose)
Results
None posted
  1. 24 Jan 2025: Trial registered
  2. 27 Jan 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.